Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 611926 | THZ1-R | 1621523-07-6 | 98% |  |
| THZ1-R is a non-cysteine reactive analog, which displays diminished activity for CDK7 | ||||
| 611925 | THZ1 Hydrochloride | 98% |  | |
| THZ1 Hcl is a novel selective and potent covalent CDK7 inhibitor with IC50(binding af | ||||
| 611905 | TGR-1202 hydrochloride | 1532533-78-0 | 98% | |
| TGR-1202 hydrochloride is an orally available, next generation PI3Kdelta inhibitor, i | ||||
| 611904 | TGR-1202 | 1532533-67-7 | 98% |  |
| TGR-1202 is an orally available, next generation PI3Kdelta inhibitor, inhibits PI3K a | ||||
| 161009029 | TDZD-8 | 327036-89-5 | 98% by HPLC |  |
| TDZD-8 protects the brain against I/R injury by inhibiting GSK-3beta activity. TDZD-8 | ||||
| 9028 | Tideglusib | 865854-05-3 | 98% |  |
| Tideglusib protects neural stem cells against NMDA receptor overactivation. Tideglusi | ||||
| 161009027 | TWS-119 | 601514-19-6 (free base); 1507095-58-0 (2 TFA salt) | 98% by HPLC |  |
| TWS119 could activate Wnt/-catenin pathway and up-regulate the expression of CD62L in | ||||
| 161009022 | Triciribine | 35943-35-2 | 98% by HPLC |  |
| Triciribine inhibits the phosphorylation, activation, and signalling of Akt-1, -2, an | ||||
| 161009006 | Tacrolimus | 104987-11-3 | 98% by HPLC |  |
| It is also used in a topical preparation in the treatment of atopic dermatitis (eczem | ||||
| 160926017 | TG100713 | 925705-73-3 | 98% by HPLC |  |
| TG100713 is an inhibitor of PI3-kinase (IC50 values are 24, 50, 165 and 215 nM for PI | ||||
| 160926011 | TG100-115 | 677297-51-7 | 98% by HPLC |  |
| TG100-115, inhibited PI3K and -(IC50 values of 83 and 235 nM, respectively), whereas | ||||
| 16071029 | Taltirelin | 103300-74-9 | 98% by HPLC |  |
| Taltirelin | ||||
| 16071020 | TMP-195 | 1314891-22-9 | 98% by HPLC |  |
| TMP-195 | ||||
| 16071003 | TC-G 1008 | 1621175-65-2 | 98% by HPLC |  |
| TC-G 1008, | ||||
| 16070909 | T-5224 | 530141-72-1 | 98% by HPLC |  |
| T-5224 is a selective inhibitor of c-Fos/activator protein-1. T-5224 ameliorates live | ||||
| 16070805 | Tanespimycin | 75747-14-7 | 98% by HPLC |  |
| Tanespimycin, also known as 17-AAG, is an orally bioavailable, small-molecule inhibit | ||||
| 121414 | Taladegib | 1258861-20-9 | 98% |  |
| Taladegib is a potent Hedgehog inhibitor with potential anticancer activity, which in | ||||
| 16070802 | Tivantinib | 905854-02-6 | 98% by HPLC |  |
| Tivantinib (ARQ-197) is an orally bioavailable small molecule inhibitor of c-Met with | ||||
| 16062203 | TAK-580 (MLN2480) | 1096708-71-2 | 98% by HPLC | -cas-1096708-71-2.png) |
| TAK-580, also known as MLN2480, BIIB024, and AMG 2112819, is an oral, selective pan-R | ||||
| 16060302 | trovirdine | 149488-17-5 | 98% by HPLC |  |
| trovirdine | ||||
| 652601 | Taprenepag(CP-544326) | 752187-80-7 | 98% by HPLC | -cas-752187-80-7.png) |
| Taprenepag is the active metabolite of PF-04217329. | ||||
| 032406 | Trofinetide | 853400-76-7 | 98% |  |
| Trofinetide is a glypromate (or Gly-Pro-Glu) analog and neuroprotectant. | ||||
| 030302 | Tyrosine kinase inhibitor | 1021950-26-4 | 98% |  |
| Coming soon! | ||||
| 012009 | Tenalisib | 1639417-53-0 or 1693773-94-2 | 98% |  |
| Tenalisib is a potent and selective dual PI3K/ inhibitor that inhibited growth of B-c | ||||
| 011903 | Tanzisertib | 899805-25-5 | 98% |  |
| Tanzisertib is a potent, selective, and orally active JNK inhibitor with potential an | ||||
| 011812 | TH-302 | 918633-87-1 | 98% |  |
| TH-302 is selective hypoxia-activated prodrug targeting hypoxic regions of solid tumo | ||||
| 011810 | Tradipitant | 622370-35-8 | 98% |  |
| Tradipitant is the 2nd generation neurokinin-1 receptor antagonist, which showed acti | ||||
| 011114 | TGN 255 | 871576-03-3 | 98% |  |
| Coming soon! | ||||
| 010813 | TAK-733 | 1035555-63-5 | 98% |  |
| TAK-733 is a potent and selective MEK allosteric site inhibitor for MEK1 with IC50 of | ||||
| 010502 | Tiotropium Bromide | 136310-93-5 | 98% |  |
| Tiotropium Bromide is a muscarinic acetylcholine receptor (mAChR) antagonist that blo | ||||